1. Home
  2. ARW vs GKOS Comparison

ARW vs GKOS Comparison

Compare ARW & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrow Electronics Inc.

ARW

Arrow Electronics Inc.

HOLD

Current Price

$118.12

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$120.64

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARW
GKOS
Founded
1935
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.3B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ARW
GKOS
Price
$118.12
$120.64
Analyst Decision
Sell
Strong Buy
Analyst Count
2
14
Target Price
$102.00
$127.71
AVG Volume (30 Days)
429.3K
677.3K
Earning Date
02-05-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
0.79
N/A
EPS
9.05
N/A
Revenue
$29,389,382,000.00
$469,820,000.00
Revenue This Year
$9.50
$31.33
Revenue Next Year
$4.28
$24.01
P/E Ratio
$13.05
N/A
Revenue Growth
3.16
30.38
52 Week Low
$86.50
$73.16
52 Week High
$134.74
$163.71

Technical Indicators

Market Signals
Indicator
ARW
GKOS
Relative Strength Index (RSI) 64.64 64.15
Support Level $110.06 $93.96
Resistance Level $119.50 $115.00
Average True Range (ATR) 2.63 4.48
MACD 0.55 -0.42
Stochastic Oscillator 85.32 94.40

Price Performance

Historical Comparison
ARW
GKOS

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: